Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04075526 · ClinicalTrials.gov registry record · Phase 1
Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty
A Phase 1 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 2,129
- Enrollment target
NCT04075526 is a Phase 1 study that has completed, run by NYU Langone Health. The registered enrollment target is 2,129 participants.
The verdict
NCT04075526, a Phase 1 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2,129 participants
- Enrollment target
Study Summary
This is a prospective, randomized, controlled, open label, parallel four-arm design, multi-center study to compare different intraoperative interventions in the prevention of acute PJI development.
Interventions
- OTHER Conventional
- DRUG Povidone iodine
- DRUG Vancomycin powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,129 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2025-12-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04075526
The ClinicalTrials.gov registry entry for NCT04075526 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2,129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Conventional is the first listed.
NCT04075526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04075526 about?
NCT04075526 is a clinical study titled "Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty". This is a prospective, randomized, controlled, open label, parallel four-arm design, multi-center study to compare different intraoperative interventions in the prevention of acute PJI development.
What is the current status of trial NCT04075526?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2,129 participants. The study started on 2019-10-01. Estimated completion is 2025-12-13.
What interventions are being tested in trial NCT04075526?
The interventions under investigation include: Conventional (OTHER), Povidone iodine (DRUG), Vancomycin powder (DRUG).
Who is sponsoring clinical trial NCT04075526?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.